These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38456353)

  • 1. Lipid accumulation product is a valid predictor of hepatic steatosis and nonalcoholic fatty liver disease.
    Huang Q; Tan X; Wu Q; Zhao H; Chen H; Yu X; Wang J; Huang X; Huang Y; Wei J; Wu F; Zhu H; Wang L
    Biomark Med; 2024 Feb; 18(3):123-135. PubMed ID: 38456353
    [No Abstract]   [Full Text] [Related]  

  • 2. Visceral adiposity index for the diagnosis of nonalcoholic fatty liver disease in premenopausal women with and without polycystic ovary syndrome.
    Vassilatou E; Lafoyianni S; Vassiliadi DA; Ioannidis D; Paschou SA; Mizamtsidi M; Panagou M; Vryonidou A
    Maturitas; 2018 Oct; 116():1-7. PubMed ID: 30244768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The usefulness of obesity and lipid-related indices to predict the presence of Non-alcoholic fatty liver disease.
    Sheng G; Lu S; Xie Q; Peng N; Kuang M; Zou Y
    Lipids Health Dis; 2021 Oct; 20(1):134. PubMed ID: 34629059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a clinical and laboratory-based nomogram to predict nonalcoholic fatty liver disease.
    Cen C; Wang W; Yu S; Tang X; Liu J; Liu Y; Zhou L; Yu J; Zheng S
    Hepatol Int; 2020 Sep; 14(5):808-816. PubMed ID: 32572817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender Differences in the Relationships among Metabolic Syndrome and Various Obesity-Related Indices with Nonalcoholic Fatty Liver Disease in a Taiwanese Population.
    Lin IT; Lee MY; Wang CW; Wu DW; Chen SC
    Int J Environ Res Public Health; 2021 Jan; 18(3):. PubMed ID: 33498329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-dimensional comparison of abdominal obesity indices and insulin resistance indicators for assessing NAFLD.
    Shi J; Chen J; Zhang Z; Qian G
    BMC Public Health; 2024 Aug; 24(1):2161. PubMed ID: 39123158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: assessment of non-invasive indices predicting hepatic steatosis and fibrosis.
    Polyzos SA; Goulis DG; Kountouras J; Mintziori G; Chatzis P; Papadakis E; Katsikis I; Panidis D
    Hormones (Athens); 2014; 13(4):519-31. PubMed ID: 25402369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex-specific contribution of lipid accumulation product and cardiometabolic index in the identification of nonalcoholic fatty liver disease among Chinese adults.
    Liu Y; Wang W
    Lipids Health Dis; 2022 Jan; 21(1):8. PubMed ID: 35027066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of lipid accumulation product, visceral adiposity index, and triglyceride-glucose index with subclinical organ damage in healthy Chinese adults.
    Du MF; Zhang X; Hu GL; Mu JJ; Chu C; Liao YY; Chen C; Wang D; Ma Q; Yan Y; Jia H; Wang KK; Sun Y; Niu ZJ; Man ZY; Wang L; Zhang XY; Luo WJ; Gao WH; Li H; Wu GJ; Gao K; Zhang J; Wang Y
    Front Endocrinol (Lausanne); 2023; 14():1164592. PubMed ID: 37795361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatty liver biomarkers and insulin resistance indices in the prediction of non-alcoholic fatty liver disease in Ghanaian patients.
    Bockarie AS; Nartey YA; Nsiah P; Edzie EKM; Tuoyire D; Acquah S; Eliason S; Nkum B
    Endocrinol Diabetes Metab; 2023 Nov; 6(6):e456. PubMed ID: 37814510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. External validation of the fatty liver index and lipid accumulation product indices, using 1H-magnetic resonance spectroscopy, to identify hepatic steatosis in healthy controls and obese, insulin-resistant individuals.
    Cuthbertson DJ; Weickert MO; Lythgoe D; Sprung VS; Dobson R; Shoajee-Moradie F; Umpleby M; Pfeiffer AF; Thomas EL; Bell JD; Jones H; Kemp GJ
    Eur J Endocrinol; 2014 Nov; 171(5):561-9. PubMed ID: 25298375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid accumulation product (LAP) index for the diagnosis of nonalcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis.
    Ebrahimi M; Seyedi SA; Nabipoorashrafi SA; Rabizadeh S; Sarzaeim M; Yadegar A; Mohammadi F; Bahri RA; Pakravan P; Shafiekhani P; Nakhjavani M; Esteghamati A
    Lipids Health Dis; 2023 Mar; 22(1):41. PubMed ID: 36922815
    [TBL] [Abstract][Full Text] [Related]  

  • 13.  The product of triglycerides and glucose as biomarker for screening simple steatosis and NASH in asymptomatic women.
    Simental-Mendía LE; Simental-Mendía E; Rodríguez-Hernández H; Rodríguez-Morán M; Guerrero-Romero F
    Ann Hepatol; 2016; 15(5):715-20. PubMed ID: 27493110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of nonalcoholic fatty liver disease (NAFLD) related steatosis indices in metabolic associated fatty liver disease (MAFLD) and comparison of the diagnostic accuracy between NAFLD and MAFLD.
    Chen J; Mao X; Deng M; Luo G
    Eur J Gastroenterol Hepatol; 2023 Apr; 35(4):394-401. PubMed ID: 36695773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between abdominal obesity indices and pathological features of non-alcoholic fatty liver disease: Chinese visceral adiposity index.
    Li R; Liu J; Han P; Shi R; Zhao L; Li J
    J Gastroenterol Hepatol; 2023 Aug; 38(8):1316-1324. PubMed ID: 37102199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visceral adiposity index (VAI), lipid accumulation product (LAP), and product of triglycerides and glucose (TyG) to discriminate prediabetes and diabetes.
    Ahn N; Baumeister SE; Amann U; Rathmann W; Peters A; Huth C; Thorand B; Meisinger C
    Sci Rep; 2019 Jul; 9(1):9693. PubMed ID: 31273286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The triglycerides and glucose index is strongly associated with hepatic steatosis in children with overweight or obesity.
    Simental-Mendía LE; Ortega-Pacheco CJ; García-Guerrero E; Sicsik-Aragón MA; Guerrero-Romero F; Martínez-Aguilar G
    Eur J Pediatr; 2021 Jun; 180(6):1755-1760. PubMed ID: 33492440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations Between Abdominal Obesity Indices and Nonalcoholic Fatty Liver Disease: Chinese Visceral Adiposity Index.
    Chen X; Shi F; Xiao J; Huang F; Cheng F; Wang L; Ju Y; Zhou Y; Jia H
    Front Endocrinol (Lausanne); 2022; 13():831960. PubMed ID: 35360076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visceral Adiposity Index As a Practical Tool in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis.
    Vural Keskinler M; Mutlu HH; Sirin A; Erkalma Senates B; Colak Y; Tuncer I; Oguz A
    Metab Syndr Relat Disord; 2021 Feb; 19(1):26-31. PubMed ID: 32898457
    [No Abstract]   [Full Text] [Related]  

  • 20. Application value of triglyceride-glucose index and triglyceride-glucose body mass index in evaluating the degree of hepatic steatosis in non-alcoholic fatty liver disease.
    Wang M; Chang M; Shen P; Wei W; Li H; Shen G
    Lipids Health Dis; 2023 Nov; 22(1):186. PubMed ID: 37924128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.